ACF invest as part of £4.8m round in to NoBACZ Healthcare

November 3, 2025

Livestock and equine wound care has long relied on antibiotics and cloth bandages – an approach that often falls short in harsh agricultural environments where slurry and bacteria can quickly compromise treatment.

NoBACZ Healthcare is transforming this with its patented ‘liquid bandage’ technology, developed at the University of Cambridge. Applied as a gel, dip, or spray, it forms an instant waterproof and biodegradable barrier that protects wounds, reduces infection risk, and enables faster healing – all without antibiotics.

NoBACZ has now announced its £4.8m raise to accelerate the global commercialisation of its technology. We are proud to have participated alongside The Yield Lab, Adjuvo, University of Cambridge, Parkwalk Advisors, The FSE Group, and Cambridge Enterprise Ventures.

Congratulations to Jonathan Powell, Nuno Faria, and the entire NoBACZ team. We look forward to supporting you as you redefine wound care in veterinary healthcare… and beyond.

Check out the full story in Sky News here: https://shorturl.at/iyLy4